Advertisement

Topics

Advanced Cardiac Therapeutics Company Profile

21:28 EDT 23rd June 2018 | BioPortfolio

Headquartered in Laguna Beach, California, USA, ACT specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology based on microwave radiometry.


News Articles [1643 Associated News Articles listed on BioPortfolio]

Living too far from advanced cardiac care decreases your odds of survival

(Elsevier) A new study published in the Canadian Journal of Cardiology determined that patients with acute cardiac syndrome (ACS) and cardiogenic shock (CS), who live far from the only cardiac cathete...

Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter

Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter dallar Fri, 05/04/2018 - 14:21

Medical News Today: What do elevated cardiac enzyme levels mean?

When someone is having a heart attack, they will have raised cardiac enzymes, in addition to other symptoms. A cardiac enzyme test allows for a doctor to determine whether someone is having a heart at...

Advanced maturation of human cardiac tissue grown from pluripotent stem cells

Cardiac rehab

With improved survival and and ageing population, the number of people living with coronary heart disease in the UK has increased to an estimated 2.3 million. There is increasing evidence that cardiac...

Timing of Cardiac Arrest May Affect Survival

TUESDAY, Jan. 23, 2018 -- Survival rates are rising for people who have cardiac arrest while in the hospital, a new study finds. But if cardiac arrest happens at night or on a weekend, you're more lik...

Improving Preoperative Cardiac Risk Assessments

Are current preoperative cardiac risk stratification categories too broad? This study defined the cardiac risks of individual operations, demonstrating how grouping operations leads to imprecision. ...

High-sensitive troponin T detects more cardiac infarctions than conventional ones, shows study

Five percent more cardiac infarctions detected and 11 percent fewer patients suffering a relapse. That is the result of a study of more than 80,000 patients in which two cardiac damage markers were co...

PubMed Articles [3155 Associated PubMed Articles listed on BioPortfolio]

Advanced cardiac imaging techniques assist in characterizing a cardiac mass and directing management.

Advanced imaging techniques, including contrast echocardiography and CMR, provided valuable characterization and evaluation of a boy with an unusual cardiac mass. Imaging features assisted with differ...

Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Cancer therapeutics-related cardiac dysfunction (CTRCD) is a well-established adverse effect resulting from a number of cancer therapeutics. Newer immunotherapy has been associated with cardiomyopathy...

Cardiac sarcoidosis: diagnostics, treatment and follow-up.

Sarcoidosis is a generalised granulomatous disorder of unknown aetiology. Cardiac involvement may affect conduction system, myocardium, valvular apparatus and pericardium. Clinical spectrum ranges fro...

Adherence to Advanced Cardiovascular Life Support (ACLS) Guidelines During In-Hospital Cardiac Arrest Is Associated With Improved Outcomes.

Identifying modifiable factors associated with survival following in-hospital cardiac arrest is crucial. The purpose of this study was to determine the extent to which adherence to the 2010 American H...

Cardiac repair by epicardial EMT: Current targets and a potential role for the primary cilium.

Despite therapeutic advances that have prolonged life, myocardial infarction (MI) remains a leading cause of death worldwide and imparts a significant economic burden. The advancement of treatments to...

Clinical Trials [7479 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

An Extension Study for T-1101 (Tosylate) to Treat Advanced Refractory Solid Tumorsfor

T-1101 is a novel anti-cancer agent being developed by Taivex Therapeutics Corporation, and is being studied in a phase I dose escalation trial, protocol TAI-001. That trial's primary aim ...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Companies [2333 Associated Companies listed on BioPortfolio]

Advanced Cardiac Therapeutics, Inc.

Headquartered in Laguna Beach, Calif., privately held Advanced Cardiac Therapeutics, Inc. specializes in advanced irrigated cardiac catheter ablation systems with proprietary temp...

Advanced Cardiac Therapeutics

Headquartered in Laguna Beach, California, USA, ACT specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology based on microwave radiometr...

Cardiac Insight, Inc.

Cardiac Insight, Inc. (www.cardiacinsightinc.com) is a U.S. developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex ...

Medicomp, Inc.

Medicomp, Inc., founded in 1981, designs, develops and provides advanced cardiac monitoring products and services using the most sophisticated and reliable ambulatory heart-monitoring systems availabl...

Myogen

Research and development of therapeutics based on signaling pathways in cardiac, hypertrophy, myosin heavy chain research and gene/protein expression profiling using its human cardiac tissue bank.

More Information about "Advanced Cardiac Therapeutics" on BioPortfolio

We have published hundreds of Advanced Cardiac Therapeutics news stories on BioPortfolio along with dozens of Advanced Cardiac Therapeutics Clinical Trials and PubMed Articles about Advanced Cardiac Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Cardiac Therapeutics Companies in our database. You can also find out about relevant Advanced Cardiac Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record